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Abstract
Purpose Especially in elderly and multimorbid patients, Coronavirus Disease 2019 (COVID-19) may result in severe pneu-
monia and secondary complications. Recent studies showed pneumothorax in rare cases, but tension pneumothorax has only 
been reported once.
Case presentation A 47-year-old male was admitted to the emergency department with fever, dry cough and sore throat 
for the last 14 days as well as acute stenocardia and shortage of breath. Sputum testing (polymerase chain reaction, PCR) 
confirmed SARS-CoV-2 infection. Initial computed tomography (CT) showed bipulmonary groundglass opacities and con-
solidations with peripheral distribution. Hospitalization with supportive therapy (azithromycin) as well as non-invasive 
oxygenation led to a stabilization of the patient. After 5 days, sputum testing was negative and IgA/IgG antibody titres were 
positive for SARS-CoV-2. The patient was discharged after 7 days.
On the 11th day, the patient realized pronounced dyspnoea after coughing and presented to the emergency department again. 
CT showed a right-sided tension pneumothorax, which was relieved by a chest drain (Buelau) via mini open thoracotomy. 
Negative pressure therapy resulted in regression of the pneumothorax and the patient was discharged after 9 days of treatment.
Conclusion Treating physicians should be aware that COVID-19 patients might develop severe secondary pulmonary com-
plications such as acute tension pneumothorax.
Level of evidence V
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Background
Since its first description in Wuhan, Hubei Province, China, 
in December 2019, severe acute respiratory syndrome coro-
navirus 2 (SARS-CoV-2) has led to a pandemic, which was 
officially declared a global health emergency by the world 
health organization (WHO) on January 30, 2020 [1, 2]. Cor-
onavirus disease 2019 (COVID-19) may lead to severe viral 
pneumonia. Characteristic computed tomography (CT) find-
ings in affected patients include bilateral, multilobar ground-
glass opacities (GGO) and consolidations with peripheral 
and posterior distribution [3–6]. Aside from common symp-
toms like dry cough, fever, myalgia and/or fatigue, severe 
secondary complications are described in recently published 
studies: acute respiratory distress syndrome (ARDS), acute 
kidney or cardiac injury, secondary infection and liver dys-
function [7]. Reports of pneumothorax as a complication 
of COVID-19 are rare, and therefore, we describe a case of 
secondary tension pneumothorax.
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Case report
A 47-year-old male was admitted to our emergency depart-
ment with dry cough, shortness of breath and stenocardia. 
Body temperature on initial admission was 37.9 ℃. Due 
to a traumatic motorcycle accident, the patient had under-
gone splenectomy years ago. Because of human immu-
nodeficiency virus (HIV) infection, the patient was under 
treatment with  Dovato® 50/300 mg  (GSK®, Dolutegravir/
Lamivudine). Nadir CD4 count was 573 cells/µL (23% of 
lymphocytes) and lowest CD4/CD8 ratio 0.47 2 days after 
hospitalization compared to 1210 cells (29% of lympho-
cytes) and a CD4/CD8 ratio of 0.74 at time of admission. 
One month before, at a regular check-up, CD 4 count was 
1408 cells/µL (35% of lymphocytes) and CD4/CD8 ratio 
0.9. The patient had no previously known pulmonary or 
thoracic diseases and no history of smoking. There was 
no recent history of travel to a designated COVID-19 risk 
area, but contact to an infected individual in the patients’ 
social environment. Symptoms including dry cough, fever, 
shortness of breath and stenocardia had lasted for 14 days 
before primary admission.
Blood gas analysis (arterial) at admission showed a pH 
of 7.49,  PCO2 of 32.6 mmHg,  PO2 of 110 mmHg, and 
 SaO2 at 98.9% with 5L/min oxygen applied by nasal can-
nula, which was hence reduced to 3L/min oxygen, result-
ing in a peripheral  O2 saturation of 95%.
Polymerase chain reaction (PCR) tests of nasal and 
pharyngeal swabs and sputum were positive for SARS-
CoV-2-RNA N-gene 1, but negative for RSV, Influenza-
A and Influenza-B. HIV-1-RNA testing (PCR) showed a 
level of < 40 copies/mL.
Blood samples showed increased levels of CRP 
(10.2 mg/d), lactate dehydrogenase (LDH) (406 U/L), 
leucocytes (12.4 G/L), D-dimers (1.7 µg/mL), and inter-
leukine-6 (122  pg/mL). Procalcitonin (PCT) levels 
were ≤ 0.1 ng/mL. Neutrophil count was reduced to 35.0% 
and lymphocyte count was normal (46%).
The electrocardiogram was normal. Troponin T (hs) was 
negative (≤ 0.013).
CT scan at admission showed bipulmonary GGO and 
consolidations with a multilobar, peripheral and dorsal dis-
tribution. Pulmonary embolism, suspected due to elevated 
levels of d-dimers, was ruled out. Detailed information about 
the radiological appearance and follow-up of the patient can 
be found in the supplement.
Because of progressive coughing and shortness of breath, 
the patient received 3 mg of morphine and was admitted 
to the intermediate care ward. Further therapy consisted of 
azithromycin to prevent secondary bacterial superinfection. 
Antibody titres (Anti-SARS-CoV-2-IgG and Anti-SARS-
CoV-2-IgA) were positive and SARS-CoV-2-RNA N-gene 
1 (PCR) was negative 5 days after primary admission. The 
patient was discharged with lowering CRP levels as well as 
normalized leucocytes and interleukine-6 levels after 7 days.
Four days later, 11 days after primary admission, the 
patient admitted again to the emergency department with 
pronounced dyspnoea after coughing.
Blood gas analysis (arterial) showed a pH of 7.47,  PCO2 
of 33 mmHg,  PO2 of 64 mmHg, and  SaO2 of 94% with 3L/
min oxygen applied by nasal cannula. Clinical elevation 
showed a reduced right sided breathing sound. The electro-
cardiogram showed tachycardia (103 bpm).
Thoracic CT revealed a right-sided tension pneumotho-
rax (Fig. 1a). To relieve the tension pneumothorax, a small 
caliber chest tube (20 Charrière = French, Buelau) was 
Fig. 1  Axial CT images obtained with intravenous contrast at second 
admission show a right-sided tension pneumothorax with mediastinal 
shift to the left and right heart compression (a). Unenhanced axial 
CT images obtained 8  days after second admission show remission 
of tension pneumothorax, new soft tissue emphysema of the right 
chest wall and mild pneumomediastinum (b). Bilateral GGO and con-
solidations with peripheral distribution on both images are signs of 
COVID-19 pneumonia. CT, computed tomography; GGO, ground 
glass opacities
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inserted through a mini open thoracotomy in the 5th right 
intercostal space. Due to secondary displacement, the drain 
had to be repositioned 4 h later. Continuous negative pres-
sure (− 20 cm/H2O) led to almost complete regression of the 
pneumothorax. Five days later, clogging of the chest drain 
by a blood clot caused brief worsening of the patient’s status 
with relapse of the pneumothorax and increasing soft tissue 
emphysema. When the clot was removed, the pneumothorax 
resolved again. Follow-up CT 8 days after second admission 
confirmed good re-expansion of the right lung, residual soft 
tissue emphysema of the right chest wall and mild pneumo-
mediastinum (Fig. 1b).
The chest tube was removed after 8 days and the patient 
was discharged after 9 days (20 days after primary admis-
sion) in stable condition.
A timeline of the events is presented in Fig. 2.
Discussion
Its relatively high sensitivity and availability have made 
CT of the chest an important screening tool for COVID-19, 
especially when PCR testing capacities are limited. Charac-
teristic CT findings include pulmonary GGO and consoli-
dations, often with a bilateral, dorsal and subpleural distri-
bution. Additionally, thoracic CT plays an important role 
in the follow-up of COVID-19 patients, because it allows 
evaluation of the course of disease as well as detection of 
acute complications, such as pulmonary embolism and pneu-
mothorax [8–10].
To date, spontaneous pneumothorax has been seldom 
reported in patients with COVID-19. In one case from 
Wuhan, formation of subpleural bullae was observed on 
chest CT as a possible cause for development of mediastinal 
emphysema and pneumothorax [9]. Our patient, however, 
did not show pulmonary cysts or bullae on CT scans, neither 
before onset, nor after treatment of tension pneumothorax. 
Tension pneumothorax after infection with SARS-CoV-2 
has been described only once before in a recently published 
case report by Flower et al. [11] Larger studies showed a 
pneumothorax prevalence of 1–2% in adults with COVID-
19 [4, 7, 12, 13].
Spontaneous pneumothorax is a commonly known com-
plication in patients with ARDS, where the most frequent 
causes are pressure and volume-related alveolar rupture [14]. 
Histological examination of lung biopsy samples in a patient 
who died from COVID-19 pneumonia showed desquamation 
of pneumocytes and hyaline membrane formation, indicat-
ing ARDS [7]. Before onset of severe dyspnea, our patient 
suffered from coughing, which increases alveolar pressure. 
Considering the absence of pre-existing pulmonary condi-
tions as well as a negative smoking history, in this case we 
suspect the pneumothorax to be caused by the structural lung 
injury following a COVID-19 pneumonia.
Conclusion
We present a rare but severe complication of infection with 
SARS-CoV-2. The case of secondary tension pneumothorax 
underlines the importance of prompt and thorough clinical 
evaluation of COVID-19 patients with worsening respira-
tory status.
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